BioMarin Pharmaceutical Inc. - Company Profile and SWOT Analysis

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $175	47 Pages	MarketLine	May, 2025	MTLN20137450

Best Price Guarantee
Price	from $175
Length	47 Pages
Publisher	MarketLine
Published Date	May, 2025
SKU	MTLN20137450

BioMarin Pharmaceutical Inc. - Company Profile and SWOT Analysis

Summary

BioMarin Pharmaceutical Inc. - Company Profile and SWOT Analysis, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

BioMarin Pharmaceutical Inc. (BioMarin) is a biotechnology company dedicated to the research, development, and commercialization of medicines for rare genetic disorders. Its key products include therapies for mucopolysaccharidosis, achondroplasia, phenylketonuria, severe hemophilia A, and neuronal ceroid lipofuscinosis type 2, among others. BioMarin's medications are provided to patients through hospitals, non-US government agencies, authorized distributors, and select larger pharmaceutical wholesalers under the brand names Vimizim, Palynziq, Brineura, and Kuvan. It distributes products in the Americas, Asia, the Middle East, and Europe. Operates manufacturing facilities in the US and Ireland. BioMarin is headquartered in San Rafael, California, the US.

Scope

Detailed information on BioMarin Pharmaceutical Inc. required for business and competitor intelligence needs
A study of the major internal and external factors affecting BioMarin Pharmaceutical Inc. in the form of a SWOT analysis
An in-depth view of the business model of BioMarin Pharmaceutical Inc. including a breakdown and examination of key business segments
Intelligence on BioMarin Pharmaceutical Inc.'s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
News about BioMarin Pharmaceutical Inc., such as business expansion, restructuring, and contract wins
Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

Gain understanding of BioMarin Pharmaceutical Inc. and the factors that influence its strategies.
Track strategic initiatives of the company and latest corporate news and actions.
Assess BioMarin Pharmaceutical Inc. as a prospective partner, vendor or supplier.
Support sales activities by understanding your customers' businesses better.
Stay up to date on BioMarin Pharmaceutical Inc.'s business structure, strategy and prospects.

Company Snapshot: BioMarin Pharmaceutical Inc.: Company Overview; BioMarin Pharmaceutical Inc.: Overview and Key Facts; BioMarin Pharmaceutical Inc.: Overview; BioMarin Pharmaceutical Inc.: Key Facts; BioMarin Pharmaceutical Inc.: Key Employees; BioMarin Pharmaceutical Inc.: Key Employee Biographies; BioMarin Pharmaceutical Inc.: Major Products and Services; BioMarin Pharmaceutical Inc.: Management Statement; BioMarin Pharmaceutical Inc.: Locations and Subsidiaries; BioMarin Pharmaceutical Inc.: Key Competitors; BioMarin Pharmaceutical Inc.: Company Analysis; BioMarin Pharmaceutical Inc.: Business Description; BioMarin Pharmaceutical Inc.: SWOT Analysis; BioMarin Pharmaceutical Inc.: SWOT Overview; BioMarin Pharmaceutical Inc.: Strengths; BioMarin Pharmaceutical Inc.: Weaknesses; BioMarin Pharmaceutical Inc.: Opportunities; BioMarin Pharmaceutical Inc.: Threats; BioMarin Pharmaceutical Inc.: Corporate Financial Deals Activity; BioMarin Pharmaceutical Inc.: Financial Deals Overview; BioMarin Pharmaceutical Inc.: Targets and Partners; BioMarin Pharmaceutical Inc.: Top Deals 2021 - 2025YTD*; BioMarin Pharmaceutical Inc.: Advisors; BioMarin Pharmaceutical Inc.: Top Legal Advisors; BioMarin Pharmaceutical Inc.: Top Financial Advisors; BioMarin Pharmaceutical Inc.: Mergers and Acquisitions; BioMarin Pharmaceutical Inc.: Partnership; BioMarin Pharmaceutical Inc.: Divestments; BioMarin Pharmaceutical Inc.: Private Equity and Ownership; BioMarin Pharmaceutical Inc.: Recent Developments; BioMarin Pharmaceutical Inc.: News and Events Summary; BioMarin Pharmaceutical Inc.: Business Reorganization; BioMarin Pharmaceutical Inc.: Corporate Governance; BioMarin Pharmaceutical Inc.: Financial Performance; BioMarin Pharmaceutical Inc.: Market Developments; BioMarin Pharmaceutical Inc.: Red Flags/DistressSignals; BioMarin Pharmaceutical Inc.: Regulatory and Legal Events; BioMarin Pharmaceutical Inc.: Research & Development
Appendix: Contact Us; Methodology; About MarketLine
List of Tables: Table 1: BioMarin Pharmaceutical Inc.: Key Facts; Table 2: BioMarin Pharmaceutical Inc.: Key Employees; Table 3: BioMarin Pharmaceutical Inc.: Locations and Subsidiaries; Table 4: BioMarin Pharmaceutical Inc.: Key Competitors; Table 5: BioMarin Pharmaceutical Inc.: Deal Activity by Deal Type - Volume (TTM*); Table 6: BioMarin Pharmaceutical Inc.: M&A Activity by Geography (TTM*); Table 7: BioMarin Pharmaceutical Inc.: Deal Activity by Deal Type - Volume (2021 - YTD*2025); Table 8: BioMarin Pharmaceutical Inc.: M&A Average Deal Size - Value (US$m); Table 9: BioMarin Pharmaceutical Inc.: Targets and Partners; Table 10: BioMarin Pharmaceutical Inc.: Top Deals 2021 - 2025YTD*; Table 11: BioMarin Pharmaceutical Inc.: Legal Advisor Ranking by Value (US$m); Table 12: BioMarin Pharmaceutical Inc.: Financial Advisor Ranking by Value (US$m); Table 13: BioMarin Pharmaceutical Inc.: M&A Volume and Value Trend (2021 - YTD*2025); Table 14: BioMarin Pharmaceutical Inc.: M&A Activity by Geography (2021 - YTD*2025); Table 15: BioMarin Pharmaceutical Inc.: Partnership Volume and Value Trend (2021 - YTD*2025); Table 16: BioMarin Pharmaceutical Inc.: Partnership Trend by Deal Type (2021 - YTD*2025); Table 17: BioMarin Pharmaceutical Inc.: Divestments Volume and Value Trend (2021 - YTD*2025); Table 18: BioMarin Pharmaceutical Inc.: Private Equity and Ownership Volume and Value Trend (2021 - YTD*2025); Table 19: BioMarin Pharmaceutical Inc.: Private Equity and Ownership Volume by Deal Type (2021 - YTD*2025); Table 20: BioMarin Pharmaceutical Inc.: News and Events Summary; Table 21: BioMarin Pharmaceutical Inc.: Business Reorganization; Table 22: BioMarin Pharmaceutical Inc.: Corporate Governance; Table 23: BioMarin Pharmaceutical Inc.: Financial Performance; Table 24: BioMarin Pharmaceutical Inc.: Market Developments; Table 25: BioMarin Pharmaceutical Inc.: Red Flags/DistressSignals; Table 26: BioMarin Pharmaceutical Inc.: Regulatory and Legal Events; Table 27: BioMarin Pharmaceutical Inc.: Research & Development
List of Figures: Figure 1: BioMarin Pharmaceutical Inc.: Deal Activity by Deal Type - Volume (TTM*); Figure 2: BioMarin Pharmaceutical Inc.: M&A Activity by Geography (TTM*); Figure 3: BioMarin Pharmaceutical Inc.: Deal Activity by Deal Type - Volume (2021 - YTD*2025); Figure 4: BioMarin Pharmaceutical Inc.: M&A Average Deal Size - Value (US$m); Figure 5: BioMarin Pharmaceutical Inc.: M&A Volume and Value Trend (2021 - YTD*2025); Figure 6: BioMarin Pharmaceutical Inc.: M&A Activity by Geography (2021 - YTD*2025); Figure 7: BioMarin Pharmaceutical Inc.: Partnership Volume and Value Trend (2021 - YTD*2025); Figure 8: BioMarin Pharmaceutical Inc.: Partnership Trend by Deal Type (2021 - YTD*2025); Figure 9: BioMarin Pharmaceutical Inc.: Divestments Volume and Value Trend (2021 - YTD*2025); Figure 10: BioMarin Pharmaceutical Inc.: Private Equity and Ownership Volume and Value Trend (2021 - YTD*2025); Figure 11: BioMarin Pharmaceutical Inc.: Private Equity and Ownership Volume by Deal Type (2021 - YTD*2025)